UNSPSC 51313434: Phenindamine tartrate

This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19N.C4H6O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 28725X3PV8, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-1h-indeno(2,1-c)pyridine l-(+)-tartrate (1:1) but more generally known as phenindamine tartrate, which bears US NIH Compound Identifier 11290. European Medicines Agency schedules Phenindamine tartrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03745MIG.

UNSPSC 51313434 Phenindamine tartrate is a Commodity code that maps nominally to antihistamine pharmaceuticals, but recent state and local solicitations show minimal activity under this specific code. The three recent opportunities on file—a Seminole County naloxone procurement, a Texas HHS pharmacy initiative RFI, and a Minnesota cooperative purchasing alliance RFP for generic multi-source pharmaceuticals—address broader pharmaceutical supply and distribution rather than phenindamine tartrate specifically. State and local governments use this code tier for individual active pharmaceutical ingredients and finished-dose products, but the issuing bodies span a wide range of jurisdictions: county health departments (Seminole County, Florida), state health and human services agencies (Texas HHS Commission), and multistate cooperative purchasing alliances (MMCAP, administered by Minnesota Department of Administration). When state and local governments do procure under this code family, they typically source through authorized pharmaceutical wholesalers, require cGMP and DSCSA compliance, and structure awards with administrative fee models.

Geographic activity appears concentrated in the South and Upper Midwest, with Seminole County, Florida; Texas; Minnesota; and Oregon represented in the most recent opportunities. The Seminole County IFB (solicitation IFB60459723LAS), posted June 30, 2026, and due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The Minnesota MMCAP RFP (solicitation S1070000015802), posted January 20, 2026, with responses due March 26, 2026, established multiple contracts for generic pharmaceuticals and OTC products distributed across participating state and local government facilities, requiring vendors to work through AmerisourceBergen Drug Corporation, Cardinal Health, and Morris & Dickson Co. as authorized wholesalers. The Texas HHS RFI (HHS0017013), posted April 3, 2026, explored direct-to-manufacturer prescription contracting but did not solicit phenindamine tartrate specifically. The code shows limited targeted recent activity; vendors should monitor cooperative purchasing platforms and county health department RFPs for sporadic opportunities.